---
ver: rpa2
title: 'Empowering Clinicians with Medical Decision Transformers: A Framework for
  Sepsis Treatment'
arxiv_id: '2407.19380'
source_url: https://arxiv.org/abs/2407.19380
tags:
- patient
- treatment
- learning
- policy
- reinforcement
- transformers
- self-attention
- retrieval-augmented-generation
- instruction-tuning
- parameter-efficient-finetuning
- mixture-of-experts
- chain-of-thought
core_contribution: This paper introduces MeDT, a transformer-based offline RL framework
  for sepsis treatment that addresses interpretability and interactivity limitations
  of existing methods. The key innovation is conditioning on both retrospective treatment
  outcomes and prospective short-term acuity scores at each timestep, enabling clinicians
  to guide recommendations via desired patient stability improvements.
---

# Empowering Clinicians with Medical Decision Transformers: A Framework for Sepsis Treatment

## Quick Facts
- arXiv ID: 2407.19380
- Source URL: https://arxiv.org/abs/2407.19380
- Authors: Aamer Abdul Rahman; Pranav Agarwal; Rita Noumeir; Philippe Jouvet; Vincent Michalski; Samira Ebrahimi Kahou
- Reference count: 14
- Primary result: MeDT outperforms baselines on MIMIC-III for sepsis treatment with interpretable attention visualizations

## Executive Summary
This paper introduces MeDT, a transformer-based offline RL framework for sepsis treatment that addresses interpretability and interactivity limitations of existing methods. The key innovation is conditioning on both retrospective treatment outcomes and prospective short-term acuity scores at each timestep, enabling clinicians to guide recommendations via desired patient stability improvements. MeDT outperforms or matches baselines (BCQ, NFQI, DDQN, CQL) on MIMIC-III data across multiple OPE metrics (FQE, WIS, WDR), while providing interpretable attention visualizations showing model reasoning. The method generates lower IV dosages on average compared to clinician policy while maintaining similar VP trends, and produces more stable patient trajectories in evaluation.

## Method Summary
MeDT uses a Decision Transformer architecture conditioned on both Retrospective Treatment Goal (RTG) and Acuity-to-Go (ATG) to recommend vasopressor and IV fluid dosages for sepsis patients. The model takes a context of 20 timesteps of patient states and actions, along with RTG and ATG specifications, and outputs the next action. A separate state predictor is trained to model patient state evolution, enabling autoregressive evaluation of the policy. The framework is trained on MIMIC-III data with 19,633 patients, using discretized actions (25 combinations) and SAPS2 acuity scores. Training employs cross-entropy loss for actions and MSE for state prediction, with batch sizes of 64 and learning rate of 0.0006.

## Key Results
- MeDT outperforms or matches BCQ, NFQI, DDQN, CQL, DT, and BC baselines on MIMIC-III across FQE, WIS, and WDR metrics
- The method produces lower IV dosages on average compared to clinician policy while maintaining similar vital parameter trends
- Autoregressive evaluation shows MeDT generates more stable patient trajectories than baseline methods
- Attention visualizations demonstrate interpretable model reasoning by highlighting relevant patient history
- MeDT requires more samples than DT to converge but demonstrates improved generalization

## Why This Works (Mechanism)

### Mechanism 1
Conditioning on short-term acuity goals (ATG) provides more informative and granular control than binary survival reward alone. The model learns to map patient states to treatment actions while optimizing for intermediate, clinically meaningful objectives (vital sign stability) rather than only terminal outcomes. This mitigates sparse reward problems by providing dense, interpretable feedback at each timestep.

### Mechanism 2
Transformer architecture captures long-range dependencies in patient treatment histories better than RNNs, improving policy quality. Self-attention allows the model to attend to relevant past observations and actions across the full patient history in parallel, identifying complex temporal patterns that inform optimal dosage decisions.

### Mechanism 3
Autoregressive evaluation with a state predictor provides a practical way to assess policy performance in high-stakes domains where online evaluation is impossible. The state predictor models how patient states evolve given recommended treatments, enabling simulation of treatment trajectories without requiring real patient interaction.

## Foundational Learning

- **Markov Decision Process (MDP) formulation**
  - Why needed: The problem is framed as sequential decision-making where treatment actions at each timestep influence future patient states and outcomes
  - Quick check: What are the five components of an MDP tuple (S, A, P, R, S') and how do they apply to sepsis treatment?

- **Offline Reinforcement Learning**
  - Why needed: Direct interaction with patients for policy learning is unsafe; the model must learn from historical data only
  - Quick check: What distinguishes offline RL from online RL, and why is this distinction critical in healthcare applications?

- **Attention mechanisms and self-attention**
  - Why needed: The transformer uses self-attention to weigh the relevance of different historical observations and actions when making treatment decisions
  - Quick check: How does self-attention differ from recurrent processing, and what advantages does it offer for modeling long patient histories?

## Architecture Onboarding

- **Component map**: MeDT Policy -> State Predictor -> Acuity Score Calculator -> Conditioning Interface
- **Critical path**: MeDT training → State predictor training → Autoregressive evaluation loop → OPE calculation
- **Design tradeoffs**: Fixed context length (20 timesteps) vs. variable-length patient histories, discretized action space (25 combinations) vs. continuous dosage recommendations, SAPS2 acuity score vs. alternative scoring systems, separate state predictor vs. joint modeling of policy and dynamics
- **Failure signatures**: Poor performance on high-severity patients suggests insufficient coverage in training data, large variance in OPE metrics indicates instability in learned policies, attention visualizations showing uniform or noisy patterns suggest ineffective learning
- **First 3 experiments**:
  1. Train MeDT with only RTG conditioning (no ATG) and compare performance to BC baseline
  2. Train with different fixed context lengths (10, 20, 30 timesteps) and evaluate sample efficiency
  3. Implement alternative acuity-to-go heuristics (exponential decay vs. linear) and measure impact on stability metrics

## Open Questions the Paper Calls Out

### Open Question 1
How does MeDT's performance compare to clinician policy on different patient subgroups (e.g., based on comorbidities, age, or initial severity)? The paper mentions that MeDT outperforms or matches baselines, but does not explicitly compare to clinician policy across patient subgroups.

### Open Question 2
How does the choice of acuity score (SAPS2 vs. SOFA) impact MeDT's performance and interpretability? The paper mentions that SAPS2 was chosen over SOFA due to its consideration of more physiological variables, but does not explore the impact of this choice on performance.

### Open Question 3
How does MeDT's performance scale with the size of the training dataset? The paper mentions that MeDT requires more samples than DT to converge, but does not provide a detailed analysis of performance scaling with dataset size.

## Limitations

- Dataset Generalization: Relies exclusively on MIMIC-III data, limiting generalizability to other healthcare systems
- Safety and Clinical Validation: Lacks prospective clinical validation and safety testing in real-world settings
- Conditioning Interface Usability: Does not address practical usability of specifying short-term stability targets for clinicians

## Confidence

- **High Confidence**: MeDT outperforms or matches existing offline RL baselines on MIMIC-III across multiple OPE metrics; Transformer architecture with self-attention provides interpretable attention visualizations; Autoregressive evaluation framework with state predictor enables clinically relevant offline policy assessment
- **Medium Confidence**: Conditioning on both RTG and ATG improves sample efficiency compared to RTG-only approaches; Framework produces more stable patient trajectories during evaluation; Attention mechanisms effectively capture relevant long-range dependencies
- **Low Confidence**: Clinical safety and efficacy in real-world settings; Generalizability across different healthcare systems and patient populations; Practical usability of the clinician conditioning interface

## Next Checks

1. **Cross-Institutional Validation**: Evaluate MeDT on MIMIC-IV and other sepsis datasets from different healthcare systems to assess generalization and identify potential dataset-specific biases.

2. **Safety-Aware Evaluation**: Implement constraint-based evaluation metrics that explicitly measure safety violations (e.g., dangerous dosage combinations, contraindicated treatments) during autoregressive rollout.

3. **Clinical Interface Study**: Conduct a usability study with clinicians to evaluate the practicality of specifying ATG targets, including how they determine appropriate values and how the system handles invalid or conflicting specifications.